Zimu Deng

Zimu Deng

Auto-generated profile, based on publicly available information

Zimu Deng

Department of Medicine, University of California, San Francisco, San Francisco, CA 1

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZDZimu Deng
Zimu Deng
ZCZhenlu Chong
Zhenlu Chong
CLChristopher S. Law
Christopher S. Law
KMKojiro Mukai
Kojiro Mukai
FHFrances O. Ho
Frances O. Ho
ASAnthony K. Shum
Anthony K. Shum
Pathogenic COPA variants cause a Mendelian syndrome of immune dysregulation with elevated type I interferon signaling. COPA is a subunit of coat protein complex I (COPI) that mediates Golgi to ER transport. Missense mutations of the COPA WD40 domain impair binding and sorting of proteins targeted for ER retrieval, but how this causes disease remains unknown. Given the importance of COPA in Golgi–ER transport, we speculated that type I interferon signaling in COPA syndrome involves missorting of STING. We show that a defect in COPI transport causes ligand-independent activation of STING. Furthermore, SURF4 is an adapter molecule that facilitates COPA-mediated retrieval of STING at the Golgi. Activated STING stimulates type I interferon–driven inflammation in CopaE241K/+ mice that is rescued in STING-deficient animals. Our results demonstrate that COPA maintains immune homeostasis by regulating STING transport at the Golgi. In addition, activated STING contributes to immune dysregulation in COPA syndrome and may be a new molecular target in treating the disease.